Effect of Rasachandrika Vati on fibrosed piles

Pharmaceutical standardization of Rasachandrika Vati and evaluation of its anti-inflammatory activity along with its clinical efficacy in post-operative inflammation management in Shleshmika Arsha (fibrosed external haemorrhoids and internal anal papillae) - Nill

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067576

Enrollment

Registered

2024-05-17

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K649- Unspecified hemorrhoids

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Post-operative wounds of patients pre-operatively diagnosed as Shleshmika Arsha and fitting the diagnostic criteria

Exclusion criteria

Exclusion criteria: 1.Age more than 60 and below 18 years. 2.Pregnant women, Lactating mother, Major operations. 3.Patients having chronic fissure in-ano and fissure in-ano with sentinel tags or hemorrhoids. 4.Patients suffering from uncontrolled hypertension (BP more than 140/90 mmHg), uncontrolled diabetes mellitus (RBS more than 140 mg/Dl) and other major systemic disorders.

Design outcomes

Primary

Measure	Time frame
Improvement in cardinal symptomsTimepoint: Baseline, Everyday	—

Secondary

Measure	Time frame
UnspecifiedTimepoint: -	—

Countries

India

Contacts

Public ContactDr Joban Modha

ITRA, Jamnagar

jobanm@itra.edu.in9825273008

Outcome results